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Sequencing Identifies PNPLA1 Mutations in
Patients with a Phenotypic Spectrum of
Autosomal Recessive Congenital Ichthyosis:
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Hassan Vahidnezhad1,2,14, Leila Youssefian1,3,14, Amir Hossein Saeidian1, Sirous Zeinali2,4,
Parvin Mansouri5, Soheila Sotoudeh6, Mohammadreza Barzegar7, Javad Mohammadi-asl8,
Razieh Karamzadeh9,10, Maryam Abiri3, Kevin McCormick11, Paolo Fortina11,12 and Jouni Uitto1,13
Autosomal recessive congenital ichthyosis is a heterogeneous group of disorders associated withmutations in at
least nine distinct genes. To ascertain themolecular basis of ichthyosis patients in Iran, a country of approximately
80 million people with a high prevalence of customary consanguineous marriages, we have developed a gene-
targeted next generation sequencing array consisting of 38 genes reported in association with ichthyosis phe-
notypes. In a subset of nine extendedconsanguineous families,we foundhomozygousmissensemutations in the
PNPLA1 gene, six of them being distinct and, to our knowledge, previously unpublished. This gene encodes an
enzyme with lipid hydrolase activity, important for development and maintenance of the barrier function of the
epidermis. These six mutations, as well as four previously published mutations, reside exclusively within the
patatin-like subdomain of PNPLA1 containing the catalytic site. Themutations clustered around the active center
of the enzyme or resided at the surface of the protein possibly involved in the protein-protein interactions.
Clinical features of the patients showed considerable intra- and interfamilial heterogeneity. Knowledge of the
specificmutations allows identification of heterozygous carriers, assisting in genetic counseling, prenatal testing,
and preimplantation genetic diagnosis in extended families at risk of recurrence of this disorder, the incidence of
which is significantly increased in consanguineous marriages.
Journal of Investigative Dermatology (2017) 137, 678e685; doi:10.1016/j.jid.2016.11.012
INTRODUCTION
Heritable forms of ichthyoses, also referred to as generalized
Mendelian disorders of cornification, are phenotypically a
highly heterogeneous group of conditions caused by mutations
in a number of genes playing a role in keratinocyte differenti-
ation and epidermal barrier function (Baden and Digiovanna,
2013; Schmuth et al., 2013). These diseases are characterized
by scaling and hyperkeratosis with associated cutaneous and
extracutaneous features. This group of disorders is also geneti-
cally heterogeneous, with autosomal dominant, autosomal
recessive, and X-linked inheritance being described. A specific
subgroup of inherited ichthyoses is the autosomal recessive
congenital ichthyosis (ARCI), with many newborns presenting
as collodion babies, but the subsequent clinical presentation
and the spectrumof severity canbehighly variable (Richard and
Bale, 2014). In the most severe forms, such as harlequin ich-
thyosis, the disease is often fatal during the early postnatal
period, whereas at the other end of the continuum of the
spectrum, the diseasemay present with a relativelymild scaling
and variable degree of palmoplantar keratoderma. There is
considerable genetic heterogeneity in ARCI, and as many as
nine different genes are known to harbor biallelic mutations;
these include TGM1, ALOXE3, ALOX12B, NIPAL4, ABCA12,
CYP4F22, PNPLA1, LIPN, and CERS3. Previous reports have
suggested that mutations in TGM1 account for 30e65% of all
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patients with ARCI, whereas mutations in LIPN, PNPLA1, and
CERS3 have been reported only in a few consanguineous
families (Richard and Bale, 2014).
With the advent of next generation sequencing (NGS),
there has been tremendous progress in facilitating the mu-
tation detection in various heritable skin disorders, including
ichthyosis (South et al., 2015; Takeichi et al., 2013). In fact, at
least 38 different genes have now been suggested to be
associated with the ichthyotic phenotypes, either as the pri-
mary mutated genes or modifying the phenotypic presenta-
tion. To elucidate the genetic basis of ichthyosis in Iran, a
country of approximately 80 million people with high prev-
alence of customary consanguineous marriages, we devel-
oped a gene-targeted NGS array consisting of 38 genes
reported in association with ichthyosis phenotypes. Identifi-
cation of specific mutations in a large number of families has
allowed us to examine phenotype/genotype correlations with
respect to both intra- and interfamilial heterogeneity, in part
because of extensive consanguinity in these families. In this
study, we identified six distinct and, to our knowledge, pre-
viously unreported mutations in the PNPLA1 gene in nine
families.
RESULTS
Mutation detection in PNPLA1
In attempts to decipher the underlying molecular basis in
patients diagnosed with different forms of ichthyosis, we first
developed a gene-targeted NGS array that covered all coding
exons, at least 20 base pairs (bp) of the flanking intronic se-
quences, and up to 50 bp of 30-untranslated regions of 38
genes known to be associated with various forms of ich-
thyosis. The amplicon panel was designed to cover 99% of
the targeted bases, and NGS sequencing metadata indicated
that 98.0% and 95.5% of these bases had a minimum
coverage of 10! and 30!, respectively. The minimum
coverage for PNPLA1 was 188!, and the maximum coverage
was 1,509!, with a mean of 1,055!. (For details of sample
preparation, library construction, mutation detection, and
bioinformatics analysis of the data, see Materials and
Methods).
Among the total of 92 probands, each representing a distinct
extended family, with clinical diagnosis of a nonsyndromic or
syndromic form of ichthyosis (Figure 1), a subgroup of patients
representing nine families was found to have homozygous,
potentially pathogenic mutations in the PNPLA1 gene, all of the
mutations being previously unreported to our knowledge
(Table 1, Supplementary Table S1 online, and Figure 2). The
presence of these sequence variants in genomic DNA was
confirmed by bidirectional Sanger sequencing. All the sequence
variantsweremissensemutations, andbioinformatics analysis by
mutationpredictionprograms, includingPolyPhen2, FIS,GVGD,
PROVEAN, and SIFT, predicted thesemutations to be pathogenic
(Table 1). Furthermore, these sequence variants were absent in
119,654 alleles in the control population, with the exception of
the p.Asp172Asn substitution, which was reported heterozygous
in one allele (ExAC.broadinstitute.org), although our patients
were homozygous for this mutation. The segregation of these
mutations with the phenotype was confirmed by genotyping all
available family members, which showed homozygous muta-
tions in all affected individuals tested and that the tested parents
were heterozygous carriers. The patients and parents tested for
the mutations in families 1e9 are indicated in Figure 2.
In two families of no known relationship (families 1 and 2),
the same mutation, c.56C>T, p.Ser19Leu, was noted. In two
other apparently unrelated families (families 8 and 9), the
same mutation, c.514G>A, p.Asp172Asn, was present, and
in another two unrelated families (families 5 and 6), a
c.421A>G, p.Lys141Glu mutation was present (Figure 2). We
subsequently examined the possibilities that these mutations
are either results of a founder effect or are hotspot mutations.
Haplotype analysis with four intragenic single-nucleotide
polymorphisms (SNPs), which were disclosed during
sequencing of the gene, was performed for all six patients
with these mutations. The results showed two conserved
homozygosity blocks within the genomic region harboring
PNPLA1 with these mutations, suggesting a founder effect in
these Iranian patients of different ethnicity and language
groups. Specifically, families 1 and 2, both of Persian
ethnicity and with the p.Ser19Leu mutation, had the same
haplotype comprising four intragenic SNPs, including a very
rare SNP, rs34598813, within the exon 6 of PNPLA1 (minor
allele frequency: 0.08 [G]). Families 5 and 6, who had the
p.Lys141Glu mutation and were from Kurdish and Persian
backgrounds, respectively, and Families 8 and 9, who had the
p.Asp172Asn mutation, had the same unique haplotype, but
it was different from the p.Ser19Leu-related haplotype.
Of particular interest was the mutation c.100G>C,
p.Ala34Pro in Family 3, previously unreported to our
knowledge. This same Ala34 residue was previously shown
to be mutated to threonine (p.Ala34Thr) (Fachal et al., 2014).
These observations provided evidence for the critical impor-
tance of the Ala34 residue in the function of PNPLA1.
The gene-targeted sequencing panel also identified a het-
erozygous sequence variant, c.1464T>A, p.Tyr488Ter, in two
unrelated families, raising the possibility that these patients
might be compound heterozygous for PNPLA1 mutations.
However, one of these families with the ARCI phenotype was
subsequently shown to harbor a homozygous sequence
variant in another gene, ST14, previously reported in a syn-
dromic form of ichthyosis (Alef et al., 2009; Basel-Vanagaite
et al., 2007), suggesting that the heterozygous premature
termination codon causing sequence variant in PNPLA1 was
coincidental and unlikely to be pathogenic. In all probands
with homozygous PNPLA1 mutations, heterozygous
sequence variants in 37 other ichthyosis-associated genes
were also identified (see Supplementary Table S2 online). In
particular, eight of the nine probands had a heterozygous
NIPAL4 variant, p.Glu64Lys, which was absent from 60,706
unrelated control individuals in ExAC Browser (exac.
broadinstitute.org). However, this variant (NIPAL4:
NM_001099287) was found to be frequent in Iranian in-
dividuals without ichthyosis, present in 84 out of 184 inde-
pendent alleles (45.6%), indicating that p.Glu64Lys is a
common polymorphism in this population. Considering the
consanguinity in these individuals with homozygous PNPLA1
mutations, the heterozygous variants are unlikely to be of
pathological significance. However, in family 3, two allelic
variants, p.Glu64Lys and p.Val244Phe, were disclosed in the
NIPAL4 gene, previously shown to harbor mutations in
ARCI6. Although these mutations may be pathogenic or may
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Figure 1. Clinical features and histopathology of patients with PNPLA1 mutations. (aef, k, o) Note hyperkeratotic scaly lesions with ectropion, as well as (h)
hyperlinearity of the palms, and (i, j) acrogeric features on thebacks of the hands in a 7-year-old patient, and (l) of a 32-year old patient. Also note (d, g) erythroderma, (f,
g) malformation of the outer ears, and (m, n) nail dystrophy. (p) Characteristic histopathological findings include lamellar orthokeratosis, focal parakeratosis, and mild
psoriasiform acanthosis; granular layer appears normal in epidermis. In the upper dermis, there is vascular proliferation, ectasia, and sparse perivascular inflammatory
cell infiltrate. Scale bar ¼ 50 mm). (qet) Illustration of the evolvement of the clinical phenotype of the 8-year-old patient shown in d and g, showing (q, r) collodion
membrane at birth, (s, t) which resolved 1 year later. All subjects and parents of underaged patients gave written informed consent to publish their images.
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contribute to the ARCI phenotype, the discovery of the ho-
mozygous p.Ala34Pro mutation in PNPLA1 is keeping with
consanguinity noted in this family.
In one family, two heterozygous mutations in the PNPLA1
gene were identified, one of them being the nonsense variant
p.Tyr488Ter. In addition, this family had a heterozygous
nucleotide substitution, c.1469C>T, affecting the last nucle-
otide of exon 7 at the exon 7/intron 7 border. In addition to
potential amino acid substitution, p.Thr490Met, the latter
base pair substitution has potential for alteration of splicing of
intron 7, according to Human Splicing Finder (Aix Marseille
Universite´, INSERM; Desmet et al., 2009). However, the
allelic frequency of this variant, c.1469C>T (rs12197079),
was shown to be C:0.760 and T:0.240, the phenotypic fre-
quency of C/T being 0.348 (1000 Genomes Project Phase 3
Allele Frequencies; www.internationalgenome.org). Also, the
nonsense variant p.Tyr488Ter has been shown by global
sequence analysis of over 121,000 alleles to be a poly-
morphism with 26% frequency, the genotype being homo-
zygous T/T in 4,519 individuals (Lek et al., 2016). Thus, we
concluded that these two sequence variants, p.Tyr488Ter and
c.1469C>T, are coincidental, not pathogenic findings.
Predicted consequences of the mutations at the protein level
PNPLA1 has a patatin-like domain extending from Ile16 to
Thr185 that has beenproposed tohave an important role in lipid
hydrolase activity (Grall et al., 2012). This patatin-like structure
harbors a conserved catalytic center of Ser-Asp located at Ser53
and Asp172, respectively. The x-ray crystallography structure of
the Pat17 Solanum cardiophyllum (heartleaf horsenettle weed)
(Rydel et al., 2003; Wijeyesakere et al., 2014) resembling the
patatin fold in PNPLA1 has shown that these residues play a
pivotal role in enzymatic activity of the protein (Protein Data-
base entry 4PK9). Moreover, the conserved motif of serine hy-
drolase enzymes (Gly-X-Ser-X-Gly) is also present in PNPLA1
(Gly51-Thr52-Ser53-Ala54-Gly55).
All nine missense mutations discovered thus far in PNPLA1
are located within the patatin-like domain (Figure 3). The
three-dimensional model of PNPLA1 indicated that three
of the mutations reported in this study (p.Thr125Asn,
p.Ser19Leu, and p.Asp172Asn) are positioned at or adjacent
to the active site, suggesting their involvement in aberration
of catalytic activity (Figure 3). Three of these mutations
(p.Ala34Pro, p.Lys141Glu, and p.Pro163Leu) are located
at the surface of the protein, potentially involving
protein-protein interactions (Figure 3). It should be noted
that protein sequence alignment results between human
PNPLA1 (PLPL1_HUMAN) and Solanum cardiophyllum
(PAT17_SOLCD) using Clustal Omega 1.2.2 (http://www.ebi.
ac.uk/tools/msa/clustalo/) indicated that the three amino acids
mutated in patients (p.Thr125Asn, p.Pro163Leu, and
p.Asp172Asn) were conserved between these two organisms,
further strengthening the argument in support of their role in
PNPLA1 structure and/or function (data available upon request).
Intra- and interfamilial phenotypic variability
Of the 26 affected individuals with homozygous PNPLA1
mutations, 20 were available for careful clinical examination.
Eight of them were male and 12 were female, ranging in age
from 4 to 37 years. Examination showed considerable
phenotypic heterogeneity (see Supplementary Table S1).
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Although all patients had generalized ichthyosis, with more
severe involvement in the flexural areas (Figure 1o) as well as
on the scalp, some patients had fine white scales, whereas
others had large, dark, and plate-like lesions (see Figure 1e
vs. 1k). All patients had facial erythroderma, anhidrosis, and
acrogeric features on the backs of the hands. Nine out of 20
patients had malformed outer ears (Figure 1f and g). About
half of the patients had nail dystrophy in hands and/or feet
(Figure 1m). All patients had some degree of ectropion,
which in most patients prevented closure of the eyes during
sleep. Most, but not all, patients had palmoplantar kerato-
derma of varying degree, with marked hyperlinearity of the
palms (Figure 1h). Subjectively, most patients complained of
joint pains, and in some patients moderate joint laxity had
been noted, but the relation of these symptoms to ichthyosis
is not clear. Finally, for 12 of the 20 patients, there was
recorded evidence of being a collodion baby at birth.
Impact of consanguinity on mutation profile
Examination of the families with affected individuals showed
extensive consanguinity. For example, family 7 (Figure 2h)
had 10 recorded consanguineous unions, resulting in six
clinically affected individuals. All mutations identified in our
study were homozygous, attesting to the impact of consan-
guinity (see Discussion).
DISCUSSION
The PNPLA protein family comprises nine members with
lipolytic and acyltransferase activities, key elements in lipid
metabolism (Lake et al., 2005; Wilson et al., 2006). There are
three subfamilies, one of them consisting of PNPLA1-5. In
this group, mutations in PNPLA2 have been shown to result
in neutral lipid storage disease with myopathy, and mutations
in PNPLA3 have been suggested to confer susceptibility to
nonalcoholic fatty liver disease (Fischer et al., 2007; Romeo
et al., 2008; Tian et al., 2010). Four mutations have been
previously identified in PNPLA1 in patients with ARCI
(Ahmad et al., 2015; Fachal et al., 2014; Grall et al., 2012;
Lee et al., 2016). Examination of clinical features in these
patients has suggested a diagnostic clinical phenotype, the
skin findings consisting of collodion membrane at birth,
generalized ichthyosis including flexural areas of fine
greyish-white scales, moderate erythroderma, and palmo-
plantar keratoderma; this entry in the OMIM Clinical Syn-
opsis (#615024) has been designated as ichthyosis,
congenital, autosomal recessive 10 (ARCI10). Although all
patients in our study meet these clinical criteria, there is
considerable variability: for example, only 12 of 20 patients
were known to be born with collodion membrane. Further-
more, the severity of the ichthyosis was highly variable, and
the degree of palmoplantar keratoderma was varied in pre-
sentation (Figure 1). Similar variability was noted also in
members of the same family with the same mutation,
implying the influence of modifying genetic and environ-
mental factors.
PNPLA1 encodes a protein in the family with highly
conserved patatin-like domain spanning the amino acid po-
sitions 16e185. All four previously identified PNPLA1 mu-
tations and all of the total of six distinct mutations identified
in this study reside in this particular domain. Also, all six
mutations identified in our study and three out of the four
previously reported ones are missense mutations; only one is
a nonsense mutation. These observations attest to the critical
importance of the primary sequence in PNPLA1, particularly
within the patatin-like domain, in maintaining the proper
function of this protein. Although the precise function of
PNPLA1 is currently unknown, this enzyme has a high degree
of homology with PNPLA2, a major triglyceride hydrolase in
Figure 2. Family pedigrees and identification of mutations in PNPLA1 in nine families with ichthyosis. (aei) The probands are indicated by arrowheads, and the
affected individuals tested for mutations are identified by a number (family-patient) to allow reference to Supplementary Table S1. The parents of the probands in
whom the mutations were verified in the heterozygous state are indicated by red asterisks. Note the consanguinity in all families; the parents of the probands are in
most cases first cousins (Table 1). The positions of the homozygous nucleotide substitutions resulting in missense mutations are indicated by red arrows.
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many cell types (Grall et al., 2012). Extensive biochemical
experiments with wild-type and PNPLA1-deficient keratino-
cytes, as well as in Pnpla1-knockout mice, have suggested,
however, that PNPLA1 has a role in synthesis of u-O-acyl
ceramide, a sphingolipid critical for formation and mainte-
nance of epidermal barrier (Grall et al., 2012; Grond et al.,
2016; Pichery et al., 2016).
In summary, application of a gene-targeted NGS array for
identification of mutations in a large cohort of Iranian patients
from consanguineous families identified six mutations in
PNPLA1 that to our knowledge were previously unreported,
whichmore thandoubles the existing database onmutations in
this gene. The consanguinity noted in these families clearly
affects the mutations, all PNPLA1 mutations being homozy-
gous, a feature noted in other rare genetic skin diseases in
Iranian populations, as exemplified by Kindler syndrome,
epidermolysis bullosa simplex, and hyaline fibromatosis syn-
drome (Vahidnezhad et al., 2016; Youssefian et al., 2015,
2016). Examination of the patients showed considerable
intra- and interfamilial heterogeneity in clinical presentation.
Identification of specific mutations in this population with a
high degree of consanguinity will help identify heterozygous
carriers in extended families with a history of ARCI and will
facilitate counseling toward eradication of heritable skin dis-
eases, including ARCI, through genetic counseling, prenatal
testing, and preimplantation genetic diagnosis.
MATERIALS AND METHODS
Patient data
This study was approved by the institutional review board of the
Pasteur Institute of Iran, and all subjects and parents of underaged
patients gave written informed consent to participate in research and
to publish their images. In this study, 92 extended families affected
by nonsyndromic and syndromic forms of ichthyosis, diagnosed in
various medical centers in Iran, were evaluated. The families were
personally examined by dermatologists (MRB, SS, PM) and by
medical geneticists (LYand HV), who are authors, and the diagnostic
clinical features and demographic data were carefully recorded.
Criteria for inclusion were clinical presentation of ichthyosis sup-
ported in some of the patients by histopathology (Figure 1).
NGS and data analysis
DNAwas extracted from peripheral blood samples by a kit (QIAamp
Blood Maxi Kit; Qiagen, Valencia, CA) or by salting-out method.
DNA concentration was measured using a Qubit 2.0 fluorometer
(Life Technologies, Carlsbad, CA). Target enrichment was performed
using the TruSeq Custom Amplicon kit (Illumina, San Diego).
DesignStudio (Illumina) was used for library design. All coding
exons, at least 20 bp of the intron at each intron-exon boundary, and
up to 50 bp of 30-untranslated regions were targeted. The designed
library contained 38 genes (ABCA12, ABHD5, AGPS, ALDH3A2,
ALOX12B, ALOXE3, AP1S1, ARSE, CERS3, CLDN1, CYP4F22, EBP,
ELOVL4, GJB2, GJB3, GJB4, GJB6, KRT1, KRT10, KRT2, KRT9,
LIPN, LOR, NIPAL4, PEX7, PHYH, PNPLA1, PNPLA2, POMP,
SLC27A4, SNAP29, SPINK5, ST14, STS, TGM1, TGM5, VPS33B,
and ZMPSTE24) divided into 351 targets covered by 558 amplicon
probes, which were designed to cover 99% of targeted bases. A total
of 93.2% of the reads were aligned to the human genome, with the
mean coverage of the target region being 493!. In addition, only
0.4% of bases of the target region were not covered by any sequence
read, indicating that 99.6% of all target region bases were
sequenced at least once. Genomic DNA from 92 probands, each
Figure 3. Gene and protein structures
of PNPLA1 and the positions of
pathogenic mutations. (a) ThePNPLA1
gene consists of eight exons with their
sizes (bp) indicated in parenthesis. (The
introns are not drawn to scale). The
genomic sequences encoding patatin-
like and proline-rich domains are
indicated. Amino acid residues essential
for enzymatic activity are indicated by
yellow triangles. The positions of
mutations identified in this study that
were, to our knowledge, previously
unreportedare indicated in redabove the
gene structure, and those previously
reported are in black below.Note that all
mutations residewithin thegenesegment
encoding the patatin-like protein
domain. (b) Structural representation of
patatin-like domain of PNPLA1 (residues
Ile16-Thr185) with the catalytic center
adjacent to residue Ser53 being shown
by dashed circle with yellow overlay.
Mutations that are likely to interfere with
catalytic activity are colored in pink.
Mutations that are located at the protein
interface are indicated in green.Oxygen,
hydrogen, nitrogen, and carbon atoms
are in red, white, blue, and cyan,
respectively (stick-and-ball structures).
Aa, aminoacids; bp, basepairs; Ex, exon;
TGA, stopcodon;UTR, translated region.
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representative of a distinct extended family, and two Illumina con-
trols were multiplexed using dual indexing with 12 primary indexes
and eight secondary indexes. Dual-indexed samples were normal-
ized to be equimolar and were pooled together following manu-
facturer’s recommendations. The pool was sequenced on a single
MiSeq flow-cell (Illumina). Reads were paired end at 2 ! 225 nu-
cleotides with dual indexes, and a total of 8.49 giga-base pairs were
generated. All samples passed quality control. Reads were aligned to
the human genome version hg19 (Lander et al., 2001) using the
BaseSpace MiSeq Reporterworkflow version 2.4 TruSeq Amplicon
App by Illumina. This software implements the banded Smith-
Waterman algorithm in the targeted regions (specified in the Illu-
mina manifest file). Picard Tools ReorderSam was used to properly
format each alignment file (https://broadinstitute.github.io/picard/).
Genome Analysis Took Kit tools RealignerTargertCreator, Indel-
Realigner, BaseRecalibrator, and PrintReads were used to pre-
process the alignments, utilizing local alignments and base quality
score distributions to optimize alignment accuracy. Variants were
called with GATK HaplotypeCaller.
PCR and Sanger sequencing
PCR was performed using Taq polymerase (Qiagen) according to
the manufacturer’s instructions. Amplification of the PNPLA1 gene
was performed with eight pairs of newly designed primers (se-
quences available upon request), spanning all eight exons and the
flanking intronic sequences. The PCR products were bidirectionally
sequenced using an automated sequencer (3730; Applied Bio-
systems, Foster City, CA). The mutation positions are reported in
reference to NM_001145717 (cDNA) and NP_001139189
(protein).
Protein modeling
Three-dimensional structures were modeled using SWISS-MODEL
(available at http://swissmodel.expasy.org/). Hydrogen atoms were
added by Reduce 3.23 (Word et al., 1999). Mutant and wild-type
structures were generated using the psfgen plugin (version 1.6.4)
of the Visual Molecular Dynamics (Humphrey et al., 1996). The
Nanoscale Molecular Dynamics software package was used for
energy minimization by conjugate gradient algorithm for 10,000
steps to remove bad contacts (Phillips et al., 2005). Molecular
graphics were created by VMD 1.9.2.
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